Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Lubeck

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
In Vivo (Athens, Greece)|March 1, 1991
Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharideZ Steplewski, M D Lubeck, D Scholz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
The interaction of murine IgG subclass proteins with human monocyte Fc receptorsM D Lubeck, Z Steplewski, F Baglia, et al.
Vaccine|April 9, 1999
Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoidM V Chengalvala, R A Bhat, B M Bhat, et al.
Vaccine|July 1, 1991
Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogsM Chengalvala, M D Lubeck, A R Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamstersJ E Morin, M D Lubeck, J E Barton, et al.
Seminars in Respiratory Infections|December 1, 1989
Current use and future directions of adenovirus vaccineM J Gurwith, G S Horwith, C A Impellizzeri, et al.
The Journal of General Virology|January 1, 1994
Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogsM V Chengalvala, B M Bhat, R Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variantsZ Steplewski, G Spira, M Blaszczyk, et al.
Vaccine|April 1, 1995
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virusK H Hsu, J E Crowe, M D Lubeck, et al.
Vaccine|February 1, 1997
Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzeesM V Chengalvala, B M Bhat, R A Bhat, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
In Vivo (Athens, Greece)|March 1, 1991
Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharideZ Steplewski, M D Lubeck, D Scholz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
The interaction of murine IgG subclass proteins with human monocyte Fc receptorsM D Lubeck, Z Steplewski, F Baglia, et al.
Vaccine|April 9, 1999
Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoidM V Chengalvala, R A Bhat, B M Bhat, et al.
Vaccine|July 1, 1991
Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogsM Chengalvala, M D Lubeck, A R Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamstersJ E Morin, M D Lubeck, J E Barton, et al.
Seminars in Respiratory Infections|December 1, 1989
Current use and future directions of adenovirus vaccineM J Gurwith, G S Horwith, C A Impellizzeri, et al.
The Journal of General Virology|January 1, 1994
Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogsM V Chengalvala, B M Bhat, R Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1985
Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variantsZ Steplewski, G Spira, M Blaszczyk, et al.
Vaccine|April 1, 1995
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virusK H Hsu, J E Crowe, M D Lubeck, et al.
Vaccine|February 1, 1997
Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzeesM V Chengalvala, B M Bhat, R A Bhat, et al.
Pageof 4